Hyaluronate microneedles can painlessly collect skin specimens for gene expression analysis, identifying specific biomarkers — including peptides like cathelicidin and IGF-1 — for different skin types.
33 subjects, 5 skin types profiled with painless microneedlesFull transcriptome analysis from minimally invasive sampling identified specific gene biomarkers including peptides (cathelicidin, IGF-1) for each skin type
What the researchers found
Biocompatible microneedles made of sodium hyaluronate successfully collected skin specimens from 33 subjects for full transcriptome analysis. The researchers identified specific gene biomarkers correlating with five skin conditions: COL1A1, FN1, and PINK1 for skin aging; FLG, KLF4, and LOR for hydration; GPNMB, MLANA, and TYR for pigmentation; IGF1, MPZL3, and AQP3 for oily skin; and PGF, CYR61, RBP4, TAC1, CAMP (cathelicidin antimicrobial peptide), MMP9, MMP3, MMP12, and CCR1 for sensitive skin. The biomarkers correlated with age, device measurements, lactic acid stinging test scores, and visual assessments.
Why it matters
Getting accurate genetic information from skin normally requires a biopsy — an invasive procedure that leaves a wound. This study demonstrates that dissolving microneedles can collect enough RNA for comprehensive gene analysis, opening the door to painless, office-based skin diagnostics. The peptide connection is notable: cathelicidin (CAMP/LL-37), an antimicrobial peptide, emerged as a biomarker for sensitive skin, and IGF-1 (a peptide growth factor) was linked to oily skin.
The numbers in context
n=33 subjects · 5 skin types assessed · Hyaluronate microneedles · Full microarray transcriptome · Multiple biomarkers per skin type
How the study worked
33 subjects with varying skin conditions (aging, dryness, pigmentation, oiliness, sensitivity) were recruited. Skin types were classified using age, non-invasive measurement devices, a 10% lactic acid stinging test, and visual acne assessment. Skin specimens were collected from the face using biocompatible sodium hyaluronate microneedles. Total RNA was extracted and analyzed using microarray-based transcriptome profiling. Correlations between gene expression biomarkers and skin condition parameters were calculated.
Who was studied
33 subjects with different skin conditions (aging, dry, pigmented, oily, sensitive skin)
What this study cannot tell us
Small sample of 33 subjects limits statistical power and generalizability across diverse skin types and ethnicities. The microneedle sampling depth may differ from deeper skin biopsies, potentially missing dermal biomarkers. No comparison to traditional biopsy was included to validate equivalence. The identified biomarkers need replication in larger cohorts.
How to read the evidence
Small proof-of-concept study with 33 subjects. Demonstrates feasibility of microneedle sampling for transcriptomics but requires replication in larger, more diverse cohorts before clinical application.
When this study was published
Published in 2022 in Skin Research and Technology. Microneedle diagnostics is a rapidly advancing field, and this study represents an early demonstration of the sampling-for-analysis approach.
The bigger picture
Microneedle technology is rapidly evolving beyond drug delivery into diagnostics. This study shows microneedles can extract biological information from skin, not just push substances into it. The identification of peptide biomarkers like cathelicidin for sensitive skin connects microneedle diagnostics to the broader field of peptide biology. If validated at scale, this approach could enable precision dermatology — tailoring treatments based on each patient's actual gene expression rather than visual appearance alone.
Questions still open
- Can microneedle skin sampling replace traditional biopsies for dermatological gene expression studies?
- Does cathelicidin (LL-37) elevation actively contribute to skin sensitivity, or is it merely a marker of inflammation?
- Could this technique be used to monitor treatment response in real-time with repeat painless sampling?
Common questions
How do microneedles collect skin samples without pain?
What do peptide biomarkers like cathelicidin tell us about skin type?
Read the original research
Minimally invasive skin sampling and transcriptome analysis using microneedles for skin type biomarker research.
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 28(2), 322-335
Citation
Kim, Seo Hyeong; Kim, Ji Hye; Lee, Sung Jae; Jung, Min Sook; Jeong, Do Hyeon; Lee, Kwang Hoon. (2022). Minimally invasive skin sampling and transcriptome analysis using microneedles for skin type biomarker research.. Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 28(2), 322-335. https://doi.org/10.1111/srt.13135